Publications by authors named "Ellen Meijer"

Claim this Profile
A
A systematic review and meta-analysis of lameness scoring methods and the prevalence of lameness of dairy cows in Northwest Europe.
Wesley Wessels, Eddie A M Bokkers, Imke J M de Boer, Ellen Meijer, T Bas Rodenburg

J Dairy Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addition of mycophenolate mofetil to a calcineurin inhibitor and post-transplant cyclophosphamide results in lower incidence of extensive chronic graft-versus-host disease in HLA-matched allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in complete remission: a matched-pair analysis on behalf of the Acute Leukemia Working Party of the EBMT.
Giorgia Battipaglia, Myriam Labopin, Aleksandr Kulagin, Jurgen Versluis, Goda Choi, Ellen Meijer

Bone Marrow Transplant· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.
Man Wai Tang, Deborah Van der Tuin, Mesire Aydin, Jarom Heijmans, Arjan A Van de Loosdrecht, Ellen Meijer

Eur J Haematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-transplant cyclophosphamide separates graft-versus host disease and graft versus leukemia effects after HLA-matched stem-cell transplantation for acute myeloid leukemia.
Avichai Shimoni, Christophe Peczynski, Myriam Labopin, Alexander Kulagin, Ellen Meijer

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time-restricted versus standard-duration immunosuppression after allogeneic hematopoietic stem cell transplantation: Results of the prospective randomized HOVON-96 trial.
Annoek E C Broers, Ellen Meijer, Bronno van der Holt, Cornelis N de Jong, Erfan Nur

Hemasphere· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early behavioral indicators of aberrant feces in newly-weaned piglets.
Vivian L Witjes, Fleur Veldkamp, Francisca C Velkers, Ingrid C de Jong, Ellen Meijer

Porcine Health Manag· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older MRD vs. younger MUD in patients older than 50 years with AML in remission using post-transplant cyclophosphamide.
Simona Piemontese, Myriam Labopin, Goda Choi, Annoek E C Broers, Jacopo Peccatori, Ellen Meijer

Leukemia· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematopoietic stem cell transplantation for DLBCL: a report from the European Society for Blood and Marrow Transplantation on more than 40,000 patients over 32 years.
Philipp Berning, Mathilde Fekom, Maud Ngoya, Anthony H Goldstone, Peter Dreger, Ellen Meijer

Blood Cancer J· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Younger unrelated donors may be preferable over HLA match in the PTCy era: a study from the ALWP of the EBMT.
Jaime Sanz, Myriam Labopin, Goda Choi, Alexander Kulagin, Jacopo Peccatori, Ellen Meijer

Blood· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic Stem Cell Transplantation in Patients >40 Years of Age With Acute Lymphoblastic Leukemia: Reduced Intensity Versus Myeloablative Conditioning.
Aniko Sijs-Szabo, Avinash G Dinmohamed, Jurjen Versluis, Bronno van der Holt, Mar Bellido, Ellen Meijer

Transplantation· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT.
Jia Chen, Myriam Labopin, Thomas Pabst, Xi Zhang, Erlie Jiang, Ellen Meijer

Bone Marrow Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT.
Jaime Sanz, Myriam Labopin, Thomas Pabst, Jurjen Versluis, Gwendolyn Van Gorkom, Ellen Meijer

Bone Marrow Transplant· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning.
Mesire Aydin, David C de Leeuw, Caroline E Rutten, Otto J Visser, Man Wai Tang, Ellen Meijer

Br J Haematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Ellen Meijer

Bone Marrow Transplant· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An early post-transplant relapse prediction score in multiple myeloma: a large cohort study from the chronic malignancies working party of EBMT.
Meral Beksac, Simona Iacobelli, Linda Koster, Jan Cornelissen, Laimonas Griskevicius, Ellen Meijer

Bone Marrow Transplant· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remission.
Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Didier Blaise, Sergey Bondarenko, Ellen Meijer

Br J Haematol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of Nonrelapse Mortality in Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation With Posttransplantation Cyclophosphamide-based Graft Versus Host Disease Prophylaxis.
Sjoerd J F Hermans, Jurjen Versluis, Myriam Labopin, Sebastian Giebel, Yvette van Norden, Ellen Meijer

Hemasphere· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profiling the Fungal Microbiome after Fecal Microbiota Transplantation for Graft-versus-Host Disease: Insights from a Phase 1 Interventional Study.
Yannouck F van Lier, Thierry Rolling, Gabriel K Armijo, Bing Zhai, Nienke J E Haverkate, Ellen Meijer

Transplant Cell Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT.
Alexandros Spyridonidis, Myriam Labopin, Eolia Brissot, Ivan Moiseev, Jan Cornelissen, Ellen Meijer

Bone Marrow Transplant· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual behavioral correlates of tail biting in pre-finishing piglets.
Marc Bagaria, Laura Kuiper, Ellen Meijer, Elisabeth H M Sterck

Front Vet Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT.
Christian Koenecke, Dirk-Jan Eikema, Sheree Hazelaar, Thomas Schroeder, Victoria Potter, Ellen Meijer

Bone Marrow Transplant· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT.
Kavita Raj, Dirk-Jan Eikema, Vipul Sheth, Linda Koster, Liesbeth C de Wreede, Ellen Meijer

Blood Cancer J· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trial.
Annoek E C Broers, Cornelis N de Jong, Katerina Bakunina, Mette D Hazenberg, Marinus van Marwijk Kooy, Ellen Meijer

Blood Adv· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of a 5-dose pneumococcal vaccination schedule following allogeneic hematopoietic stem cell transplantation.
Hannah M Garcia Garrido, Sabine Haggenburg, Marieke C E Schoordijk, Ellen Meijer, Michael W T Tanck

Am J Hematol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose melphalan in 1 day versus over 2 days followed by autologous stem cell transplantation as consolidation treatment in patients with multiple myeloma.
Mesire Aydin, Man Wai Tang, Mariëlle J Wondergem, David C de Leeuw, Jurgen J Wegman, Ellen Meijer

Br J Haematol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis